ARID1A and cancer: It is important to note that SLC7A11 and TP53 were part of the 15‐gene signature found to be highly predictive for the outcome of patients with HCC ARID1A is a commonly mutated gene in cancer and was reported as a suppressor of tumour initiation in liver cancer.33